Biomerica (BMRA) Accounts Payables (2011 - 2026)

Biomerica has disclosed Accounts Payables across 16 years of filings, most recently posting $730000.0 for Q1 2026.

• Accounts Payables for Q1 2026 came in at $730000.0, up 15.51% year-over-year; the trailing twelve-month figure through Feb 2026 was $730000.0 (up 15.51% YoY), and the FY2025 annual result was $672000.0, up 20.0% from the prior year.
• Accounts Payables came in at $730000.0 for Q1 2026 at Biomerica, down from $740000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $2.6 million in Q1 2022 to a low of $344000.0 in Q2 2023.
• The 5-year median for Accounts Payables is $713000.0 (2023), against an average of $822728.4.
• Across the five-year window, Accounts Payables jumped 245.02% in 2022 and slumped 85.16% in 2023, its largest moves.
• Biomerica's Accounts Payables stood at $670074.0 in 2022, then increased by 16.85% to $783000.0 in 2023, then gained by 8.3% to $848000.0 in 2024, then slipped by 12.74% to $740000.0 in 2025, then dropped by 1.35% to $730000.0 in 2026.
• The last three Accounts Payables figures came in at $730000.0 (Q1 2026), $740000.0 (Q4 2025), and $681000.0 (Q3 2025), per Business Quant data.